Biotechnology

Upside Foods

Medium1/1 relationships sourcedProfile verified Jul 27, 2026

30-Second Executive Brief

Executive Assessment

Upside Foods functions as a regional institution within Biotechnology, backed by 80% sourcing coverage, with a stable competitive position.

  • Maintains 1 mapped relationship across the graph
  • 80% sourcing coverage across sourced relationships
  • Tracked as regional institution within the Biotechnology category

Executive Snapshot

Strategic Role
Regional Institution
Sourcing Coverage
80%
View Methodology →

Computed live from this entity's own relationships and evidence: how many relationships carry at least one linked citation, weighted with citation recency and source type — independent of Strategic Importance, and not a prediction. Not a hand-typed number; recalculated on every read.

Ecosystem Influence
Moderate
Strategic Momentum
Insufficient Data

Coverage

Mapped Relationships
1
Technology Domains
2

Strategic Implications

  • Central node connecting multiple strategic ecosystems
  • Directly influences technology and capital flows
  • Material relevance to downstream dependency mapping

Top Opportunities

Continued public exposure (e.g. MrBeast taste test) could help build consumer acceptance ahead of eventual capacity re-expansionRefocused investment in the existing EPIC site suggests a more capital-disciplined path to scale than the paused Rubicon facility

Top Risks

Cultivated meat sector broadly faces a challenging funding environment, with Upside pausing capacity expansion and cutting jobsRegulatory approval exists only in the US to date, limiting near-term global scale

Critical Dependencies

Continue to Dependency Graph ↓

Pioneer in cultivated (lab-grown) meat and one of only two US companies, alongside Good Meat, to have gained USDA regulatory approval for cell-based meat products (June 2023), backed by $611 million in total funding. Facing a challenging funding environment, Upside paused construction of its Rubicon cell-based production facility in Glenview, Illinois in 2024 to refocus resources on doubling investment in its existing EPIC production site in California, and has more recently cut jobs amid the same funding pressure. The company gained wide public exposure when creator MrBeast toured its production site and could not distinguish its cultivated chicken from conventional chicken in a taste test.

Sources

Every claim traced to a primary source — evidence, recent activity, and insider filing behavior, all in one place.

Evidence

1 source

  • Yahoo FinanceLab-grown meat business Upside Foods to cut jobsnews

Acquisition & Investment Fit

AI-reasoned, generated only from entities already in InsightNodes's own graph — a hypothetical strategic-fit exercise, not real M&A intelligence or a signal that any deal is planned or in progress.

Relationship Map

The relationships surrounding Upside Foods — ownership, dependencies, regulation, technology and market context. Click any node to make it the new center, 2 levels deep.

Connection type

Sign in free to click a node and explore →

Click any node to make it the new center. Scroll to zoom, drag to pan.

The Story So Far

Jun 2023: Gains USDA approval for cultivated chickenJan 2024: Pauses Rubicon facility constructionFeb 2026: Lab-grown meat business Upside Foods to cut jobs

Auto-generated from this entity's dated milestones, relationship updates, and sourced evidence — not AI-written, just sorted.

Upside Foods's Timeline

A sourced, dated history of Upside Foods's key moments — founding to present.

  1. Jun 2023 · Gains USDA approval for cultivated chicken

    Upside Foods became one of the first two US companies (alongside Good Meat) to gain USDA regulatory approval for cultivated meat.

  2. Jan 2024 · Pauses Rubicon facility construction

    Upside Foods paused construction of its Rubicon cell-based meat production facility in Glenview, Illinois, citing a challenging funding environment, and refocused investment on its existing EPIC site in California.